Year-over-year articles
3P BIOTECH NORWAY AS
18 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 992 709 014
Stronger earnings
Comparing Årsregnskap 2025 with 2024 for 3P BIOTECH NORWAY AS. Net result -53.1k NOK → -13.6k NOK. Equity 205.7k NOK → 192.1k NOK.
Another loss-making year
Comparing Årsregnskap 2024 with 2023 for 3P BIOTECH NORWAY AS. Net result -49.1k NOK → -53.1k NOK. Equity 258.8k NOK → 205.7k NOK.
Shrank 100% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2023 with 2022 for 3P BIOTECH NORWAY AS. Revenue 1.12m NOK → 1 121 NOK (-99.9%). Net result -35.4k NOK → -49.1k NOK. Equity 307.9k NOK…
Grew 1428% on revenue, stronger earnings, cash halved-plus
Comparing Årsregnskap 2022 with 2021 for 3P BIOTECH NORWAY AS. Revenue 73.4k NOK → 1.12m NOK (+1428.4%). Net result -53.6k NOK → -35.4k NOK. Equity 343.3k…
Shrank 24% on revenue, slipped into loss
Comparing Årsregnskap 2021 with 2020 for 3P BIOTECH NORWAY AS. Revenue 96.4k NOK → 73.4k NOK (-23.9%). Net result +3 624 NOK → -53.6k NOK. Equity 396.9k NOK…
Grew 20% on revenue, cash halved-plus
Comparing Årsregnskap 2020 with 2019 for 3P BIOTECH NORWAY AS. Revenue 80.7k NOK → 96.4k NOK (+19.5%). Net result +4 NOK → +3 624 NOK. Equity 393.2k NOK →…
Grew 203% on revenue
Comparing Årsregnskap 2019 with 2018 for 3P BIOTECH NORWAY AS. Revenue 26.6k NOK → 80.7k NOK (+203.2%). Equity 382.3k NOK → 393.2k NOK.
Shrank 27% on revenue, cash halved-plus
Comparing Årsregnskap 2018 with 2017 for 3P BIOTECH NORWAY AS. Revenue 36.6k NOK → 26.6k NOK (-27.3%). Equity 476.2k NOK → 382.3k NOK.
Grew 2965% on revenue, slipped into loss
Comparing Årsregnskap 2017 with 2016 for 3P BIOTECH NORWAY AS. Revenue 1 194 NOK → 36.6k NOK (+2965.3%). Net result +123.9k NOK → -18.3k NOK. Equity 494.5k…
Grew 119300% on revenue, fresh owner capital
Comparing Årsregnskap 2016 with 2015 for 3P BIOTECH NORWAY AS. Revenue 1 NOK → 1 194 NOK (+119300.0%). Equity -327.0k NOK → 494.5k NOK.
Cash halved-plus
Comparing Årsregnskap 2015 with 2014 for 3P BIOTECH NORWAY AS. Equity -326.1k NOK → -327.0k NOK.
Weaker earnings
Comparing Årsregnskap 2014 with 2013 for 3P BIOTECH NORWAY AS. Net result -89.9k NOK → -185.2k NOK. Equity -140.9k NOK → -326.1k NOK.
Another loss-making year
Comparing Årsregnskap 2013 with 2012 for 3P BIOTECH NORWAY AS. Equity -51.0k NOK → -140.9k NOK.
Mixed movements in the accounts
Comparing Årsregnskap 2012 with 2011 for 3P BIOTECH NORWAY AS. Equity -25.4k NOK → -51.0k NOK.
Mixed movements in the accounts
Comparing Årsregnskap 2011 with 2010 for 3P BIOTECH NORWAY AS. Equity -20.5k NOK → -25.4k NOK.
Mixed movements in the accounts
Comparing Årsregnskap 2010 with 2009 for 3P BIOTECH NORWAY AS. Equity 15.1k NOK → -20.5k NOK.
Shrank 11% on revenue, cash halved-plus
Comparing Årsregnskap 2009 with 2008 for 3P BIOTECH NORWAY AS. Revenue 24.4k NOK → 21.7k NOK (-11.2%). Equity 71.4k NOK → 15.1k NOK.
First published accounts
First year in the published series for 3P BIOTECH NORWAY AS (2008). No prior-year comparative in this dataset.